Sherry Marsh
About Sherry Marsh
Sherry Marsh is a seasoned professional in regulatory operations, currently serving as the Senior Director of Regulatory Operations at Day One Biopharmaceuticals since 2022. She has extensive experience in the field, having held various regulatory roles at several pharmaceutical companies over the past two decades.
Current Role at Day One Biopharmaceuticals
Sherry Marsh serves as the Senior Director of Regulatory Operations at Day One Biopharmaceuticals. She has held this position since 2022, contributing her extensive experience in regulatory affairs and operations. Based in the San Francisco Bay Area, she oversees regulatory strategies and ensures compliance with industry standards.
Previous Experience in Regulatory Operations
Sherry Marsh has a diverse background in regulatory operations, having worked with several prominent companies in the biotechnology and pharmaceutical sectors. She was a Regulatory Operations Consultant at Tobira Therapeutics from 2013 to 2020 and at FibroGen, Inc. from 2015 to 2022. Additionally, she held similar consultant roles at Cytokinetics, La Jolla Pharmaceutical Company, Portola Pharmaceuticals, and Anacor Pharmaceuticals during various periods.
Career at Gilead Sciences
Before her consulting roles, Sherry Marsh worked at Gilead Sciences as a Manager in Regulatory Operations from 2001 to 2010. In this position, she gained significant experience in managing regulatory submissions and compliance processes, which laid the foundation for her subsequent roles in the industry.
Educational Background
Sherry Marsh studied at ECVHS from 1990 to 1994. This educational background provided her with the foundational knowledge necessary for her career in regulatory operations within the pharmaceutical and biotechnology fields.